Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Levoleucovorin
×
30 days
×
Clear all
Filters
3
NCT06780111
2026-03-10
MK-3475-06E
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
298 enrolled